Skip to main content
Equibles
TFX logo

TFX · Teleflex Inc · Metrics

Track TFX — free

Use TFX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TFX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$138.98 -0.02 (-0.01%) At close · Oct 28 Q2 2026 earnings call transcript
S&P 600 member Russell 1000 member Rebalance outlook locked
Market Cap
$5.83B
Shares
42.37M
Volume · Oct 28 630.17K Avg daily vol (3M) 709.51K

TFX metrics

109 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$138.98
Market cap
$5.83B

Price action

20 metrics
Price change (1W)
+6.0%
Price change (30D)
+9.1%
Price change (3M)
+3.6%
Price change (6M)
+2.6%
Price change (YTD)
+13.9%
Price change (1Y)
+4.9%
Trailing year
Price change (5Y)
-62.0%
52-week high
$142.05
52-week low
$100.34
Change from 52-week high
-2.1%
Change from 52-week low
+38.5%
Annualized volatility
39.8%
Annualized volatility (3M)
27.2%
Beta
0.7
RSI (14D)
70.0
Price vs SMA 50
+6.1%
Price vs SMA 200
+11.5%
Avg volume (3M)
705,357
Relative volume
1.3
Average dollar volume
$92.69M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
42.37M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.7×
reciprocal yield 27.1%
EV / EBITDA
33.2×
reciprocal yield 3.0%
EV / EBIT
186.9×
reciprocal yield 0.5%
P / sales
2.6×
reciprocal yield 38.9%
P / book
2.0
reciprocal yield 50.1%
FCF yield
2.9%
TTM · current market cap
Buyback yield
4.3%
P / FCF
34.4
reciprocal yield 2.9%
P / operating cash flow
23.7
reciprocal yield 4.2%
Earnings yield
-17.8%

Historical valuation

8 metrics
P / E historical average (3Y)
32.4×
reciprocal yield 3.1%
P / E historical average (5Y)
36.9×
reciprocal yield 2.7%
EV / revenue historical average (3Y)
3.4×
reciprocal yield 29.1%
EV / revenue historical average (5Y)
4.1×
reciprocal yield 24.4%
EV / EBIT historical average (3Y)
57.1×
reciprocal yield 1.8%
EV / EBIT historical average (5Y)
42.8×
reciprocal yield 2.3%
EV / EBITDA historical average (3Y)
46.0×
reciprocal yield 2.2%
EV / EBITDA historical average (5Y)
46.0×
reciprocal yield 2.2%

Dividends & buybacks

7 metrics
Dividend yield
1.0%
Trailing 12 months
Payout ratio
—
Shareholder yield
5.3%
Dividend / share (TTM)
$1.36
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-08-14

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
54.9%
Operating margin
2.0%
Trailing 12 months
Net margin
-45.8%
Gross profit (TTM)
$1.24B
Operating profit (TTM)
$44.44M
Net income (TTM)
−$1.03B
Trailing 12 months
Diluted EPS (TTM)
$-23.29
FCF margin
7.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$51.07
Gross profit per diluted share (TTM)
$28.06
Operating profit per diluted share (TTM)
$1.02
EBITDA per diluted share (TTM)
$5.69
Net income per diluted share (TTM)
$-23.22
Operating cash flow per diluted share (TTM)
$5.56
Free cash flow per diluted share (TTM)
$3.84
Capital expenditures per diluted share (TTM)
$1.73
R&D per diluted share (TTM)
$4.14
Stock compensation per diluted share (TTM)
$0.58
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+28.9%
Year over year
Net income growth YoY
-18.7%
Revenue (TTM)
$2.25B
Trailing 12 months
EPS growth YoY
-17.7%
Shares change YoY
-1.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-10.6%
Revenue CAGR (5Y)
-4.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-82.4%
FCF CAGR (5Y)
-66.6%

Quality

14 metrics
Return on equity
-35.5%
Return on assets
-15.2%
Debt / equity
1.0
Current ratio
2.6
EBITDA (TTM)
$250.24M
Free cash flow (TTM)
$168.40M
Quick ratio
2.1
Interest coverage
0.4
Net debt / EBITDA
10.0
Return on invested capital
—
Trailing 12 months
Net cash
−$2.51B
Latest balance sheet
Cash & equivalents
$300.16M
Total assets
$6.79B
Total debt
$2.81B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$244.54M
Capital expenditures (TTM)
$76.14M
R&D (TTM)
$182.51M
SG&A (TTM)
$869.28M
Stock compensation (TTM)
$25.59M
R&D / revenue
8.1%
Stock compensation / revenue
1.1%

Ownership (13F)

9 metrics
13F filers
384
13F filer change QoQ
+17
Institutional ownership
113.3%
Conviction holders (share of 13F filers)
2.1%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.8%
Holder tenure
11.7
Price vs estimated holder cost
-0.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
25.3%

Short interest

3 metrics
Short interest
10.0%
Latest settlement · 6.0 days to cover
Days to cover
6.0d
Short-squeeze score
80 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 96943 CUSIP 879369106 13F (30d) 84 filings 77 filers Visit website Investor relations